Views & Analysis Ardelyx’s ambition to revolutionise kidney treatment A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company Ardelyx.
News FTC says Shkreli is flouting lifetime pharma ban The FTC and several US states have accused Martin Shkreli of violating a lifetime order preventing him from involvement in the pharma industry.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.